Characterization of a novel international clonal complex (CC32) of Acinetobacter baumannii with epidemic potential

Epidemiology and Infection

Volumn 142, Issue 7, 2014, Pages 1554-1558

  Da Silva, G J ^a   Van Der Reijden, T ^b   Domingues, S ^a   Mendonca N ^a   Petersen, K ^c   Dijkshoorn, L ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Virology Program   (Peru)

Author keywords

Carbapenem resistance; European clone IV; multidrug resistance

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; OXOID; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CC32; CLONE; CROSS INFECTION; EPIDEMIC; EUROPEAN CLONE IV; GENETIC TRAIT; HOUSEKEEPING GENE; INTERNATIONAL CLONE IV; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; OXA 58 GENE; PHENOTYPE; DISK DIFFUSION; EUROPEAN; HEALTH CARE SYSTEM; HUMAN; KUWAIT; MOLECULAR CLONING; UNITED STATES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; HUMANS; KUWAIT; MILITARY PERSONNEL; UNITED STATES;

EID: 84901394657     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813002288     Document Type: Article

References (12)

1. Orskov F, Orskov I. From the national institutes of health. Summary of a workshop on the clone concept in the epidemiology, taxonomy, and evolution of the Enterobacteriaceae and other bacteria. Journal of Infectious Disease 1983; 148: 346-357.
2. Dijkshoorn L, et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. Journal of Clinical Microbiology 1996; 34: 1519-1525. (Pubitemid 26161019)
3. van Dessel H, et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Research Microbiology 2004; 155: 105-112. (Pubitemid 38249559)
4. Diancourt L, et al. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010; 5: e10034.
5. Zarrilli R, et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. International Journal of Antimicrobial Agents 2013; 41: 11-19.
6. van den Broek PJ, et al. Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey. Journal of Clinical Microbiology 2009; 47: 3593-3599.
7. Petersen K, et al. Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center. Journal of Clinical Microbiology 2011; 49: 159-166.
8. Domingues S, Nielsen KM, Da Silva GJ. The blaIMP-5-carrying integron in a clinical Acinetobacter baumannii strain is flanked by miniature inverted-repeat transposable elements (MITEs). Journal of Antimicrobial Chemotherapy 2011; 66: 2667-2668.
9. Domingues S, et al. Identical miniature inverted repeat transposable elements (MITE) flanks class 1 integrons in clinical isolates of Acinetobacter spp. Journal of Clinical Microbiology 2013; 51; 2382-2384.
10. Bonnin RA, et al. Ceftazidime-susceptible and imipenem-non-susceptible OXA-58-producing Acinetobacter baumannii from the Comoros archipelago. International Journal Antimicrobial Agents 2013; 41: 297-298.
11. Metan G, et al. Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey. Infection, Genetics and Evolution 2013; 14: 92-97.
12. Higgins PG, et al. Global spread of carbapenemresistant Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 2010; 65: 233-238.